VCB-1201

N/A

Report date: 2025/07/01 16:52:53

Base Information

Drug NameVCB-1201

Drug Alias NameVCB-1201

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Marrow Infiltrating Lymphocytes > Chimeric antigen receptor Marrow Infiltrating Lymphocytes

Mechanisms of ActionB-cell maturation protein modulators

TargetsB-cell maturation protein

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxcellBio Inc

China Registration ClassN/A

Develop Information

Active CompaniesVaxcellBio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A